Stocks and InvestingStocks and Investing
Mon, May 15, 2023
Fri, May 12, 2023

Judah Frommer Reiterated (ATAI) at Buy and Held Target at $9 on, May 12th, 2023


Published on 2024-10-28 03:44:25 - WOPRAI, Judah Frommer
  Print publication without navigation


Judah Frommer of Credit Suisse, Reiterated "Atai Life Sciences N.V." (ATAI) at Buy and Held Target at $9 on, May 12th, 2023.

Judah has made no other calls on ATAI in the last 4 months.



There are 2 other peers that have a rating on ATAI. Out of the 2 peers that are also analyzing ATAI, 0 agree with Judah's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Judah


  • Elemer Piros of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Friday, March 31st, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Thursday, January 19th, 2023